Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

PROSHARES TRUST (ZBIO) Invested Capital: 2023-2025

Historic Invested Capital for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $196.4 million.

  • Zenas BioPharma's Invested Capital fell 45.35% to $196.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.4 million, marking a year-over-year decrease of 45.35%. This contributed to the annual value of $312.5 million for FY2024, which is 238.43% up from last year.
  • Latest data reveals that Zenas BioPharma reported Invested Capital of $196.4 million as of Q3 2025, which was down 18.03% from $239.6 million recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Invested Capital peaked at $359.4 million during Q3 2024, and registered a low of -$288.8 million during Q2 2024.
  • In the last 3 years, Zenas BioPharma's Invested Capital had a median value of $196.4 million in 2025 and averaged $47.0 million.
  • In the last 5 years, Zenas BioPharma's Invested Capital surged by 277.73% in 2024 and then crashed by 45.35% in 2025.
  • Over the past 3 years, Zenas BioPharma's Invested Capital (Quarterly) stood at -$225.7 million in 2023, then soared by 238.43% to $312.5 million in 2024, then slumped by 45.35% to $196.4 million in 2025.
  • Its Invested Capital was $196.4 million in Q3 2025, compared to $239.6 million in Q2 2025 and $284.3 million in Q1 2025.